Russian Pharmaceutical Forum

Russian Pharmaceutical Forum

17-06-2014 - 19-06-2014 St.Petersburg, Russia

Share your ideas with the most successful MDs of the leading pharmaceutical companies working in Russia, who will come together to discuss the most important commercial and market challenges, as well as assess the healthcare system’s key pressure points.

WHAT IS NEXT FOR THE RUSSIAN PHARMA MARKET?

Share your ideas with the most successful MDs of the leading pharmaceutical companies working in Russia, who will come together to discuss the most important commercial and market challenges, as well as assess the healthcare system’s key pressure points.

  • Kees Roks, General Manager,  Novartis Pharma Russia
  • Naira Adamian, Managing Director, Janssen, Pharmaceutical Division of Johnson & Johnson Russia & CIS
  • Andrey Potapov, Country Head, Takeda-Russia
  • M.V.Ramana, Executive Vice President - Emerging Markets, Dr.Reddys
  • Danil Blinov, Country Manager Pfizer Russia, Pfizer HCP Corporation

RESEARCH AND INSIGHTS FROM LEADING ACADEMICS AND THOUGHT LEADERS

Hear international pharmaceutical experts from several countries, who will analyze the effect of policies that mandate INN prescription and generics substitution, talk about the pros and cons of local production, as well as share their experience in advocacy, multichanneling and many other topics.

  • Shan lian Hu. Professor. School of Public Health, Fudan University, Director, Shanghai Health Development and Research Center. Shanghai Health and Family Planning Commission
  • Nikos Maniadakis, Professor of Health Services Organisation & Management and Associate Dean, National School of Public Health, Greece
  • Arthur Daemmrich, Associate Professor, Department of History and Philosophy of Medicine at the University of Kansas School of Medicine
  • Len Starnes, Digital Healthcare Expert

 

Parexel

Parexel

Back to top